Some ruthenium(III) complexes with aryl-azo 2,4-petandione as eo-ligands (LH L3H2) hav.e been synthesized and characterized spectroscopically OR, 'H NMR, UV/Vis, ESR, conductime_tric) along with elemental analysis and FAB-mass data. Their luminescent and redox properties have been studied. The antibactei'ial, anti-HIV and antitmnour activities have also been reported.
Introduction
Study of oetahedral ruthenium complexes using spectroscopic techniques is of current interest [1] [2] [3] [4] . Lahiri et al. [5] synthesized several ruthenium(Ill) complexes of N, O donors and studied their electronic and electrochemical properties. The complexes of Ru(N-N)2C12 family. (where N-N 2,2'-bipyridine and 1, 10-phenanthroline) have been found [6] unsuitable in vew of isomeric problems. Therefore, several research groups have focussed their attention on the complexes of the type [Ru(tpy) 2] 2+ family (tpy 2, 2':6', 2"-terpyridine) in spite of the fact that they exhibited less favourable photophysieal properties particularly showed weak luminescence at room-temperature with shorter excited-state lifetime. However, suitably substituted terpyridyl complexes especially 4'-substituted terpyridyl Ru(III) complexes were found to display room-temperature luminescence.
Thus, in order to avoid isomeric complexities, we selected a terpyridyl type tridentate ligand vz.
2,6-bis(2'-benzimidazolyl)pyridine. Thes selectivity of the benzimidazolyl terpyridyl ligand was also based on its involvement in the strong intramoleeular stacking interactions between the DNA strands hence in bioactivities [7] ofthe resulting complexes. In this context it is also of worth to mention that azo/hydrazo compounds have also been subjected [8] to many biological reactions such as in protein synthesis inhibition, nitrogen fixation and antitumour properties which have been understood in their action as DNA erosslinking agents. Additionally, ruthenium(Ill) chloro complexes have been reported [9] to bind covalently to calfthymus DNA. In this context reports [10] [11] Thus in view of above mentioned properties and in continuation to our earlier studies [12] [13] [14] , we found it worthwhile to synthesize, new mono and dinuelear Ru(III) chloro complexes containing aryl diazo-pentane 2,4-dione and 2,6-bis-(2'-benzimidazolyl) pyridine as ligands and to study their spectroscopic, electrochemical, luminescent and antibacterial/antitumour/anti-HIV properties.
Materials and Methods
All the solvents purchased from E. Merck were distilled using standard procedure prior to use.
Pentane2,4-dione, aniline, p-phenylenediamine, benzidine, RuCI.3H20, 2,i-_pyridine dicarboxylic acid purchased from Sigma-Aldrich were used_as su_ppli.ed whereas 2,6-bis(2'-benzimidazolyl) py_fidme was prepared by a reported [15] procedure. Te-trabutyl ammonium bromide taken frtm Merck was converted into tetrabul ammonium perehlorate (TBAP) by available procedure [16] . Caution! TBAP could be explosive so the use of small mounts or it are recommended.
Neutral alumina for column chromatography was supplied by E. Merck [12] by us whereas 2,6-bis(-2'-bermTimidazolyl) pyr!dine was prepared from 2,6-pyridine dicarboxylie acid and o-phenylenediamine in acidic media following the reported procedure [18] . A strong and sharp peak observed at 839-840 cm in the spectra of thHe complexes 4 and 5 was assigned to v(PF6").
NMR spec,tra: To get further structurdl support from H NMR spectra, one representative complex [Ru(L'H)3] 3C1 was reduced into the Ru(II) form in the presence of N-ethyl morpholine using a reported procedure [19] . The H NMR spectnnn recorded in DMSO-de showed two peaks at 8 2.6 and 2.9 ppm due to methyl protons, a complex pattern at 7-8 ppm due to phenyl protons and a singlet at b 14.20 ppm due to the NH proton. [4, 5] on ruthcnium(III) systems. Substitution of chloro groups in the complex 2 by 2,6-bis(2'-bcnzimidazolyl) pyridinc lowered the LMCT transition wavelength by 10 nm which is also consistent with the earlier report [20] . Almost double intensity of the peak observed for complex 5 as compared to complex 4 could bc considered duc to the dinuclcar nature [21] Redox properties: Rcdox properties of the ruthenium complexes have bccn studied in DMF solution (10-M) in the potential range +2V using Ag/Ag / as reference and graphite disc as working and Ag/Ag* as rcfcrcncc clcctrodcs. Rcdoxpotential (E) data arc reported in Table III . Other complexes showed only one broad oxidation peak indicating that ligand based oxidation is overlapping with the metal-based oxidation. Reductions
The complexes 1 3 showed two reduction peaks in the range -0.72 to -0.86V and -1.37 to 1.51 V whereas complexes 4 and 5 showed three reduction peaks in the range -0.72 to -0.79, -1.44 to 1.46V and-1.80 to-1.79V which were consistent with earlier report [25] . Room temperature emission spectra
Emission properties of the complexes have been studied in DMF solution (10 5 M) at room temperature and the data are presented in Table II . The complexes 1 3 after excitation at 330 nm emitted at 460, 436 and 555 nm respectively indicating that the dinuclear complex 3 emitted at lower energy than the complexes 1 and 2. The complexes 4 and 5 showed two emissions at 370, 719 and 375, 725 nm respectively. In view of an earlier report [26] two emissions in the range 370 Ru(III) Complexes of Aryl-Azo Pentane-2,4-Dione and 2,6-Bis(2 '-Benz midazolyl)-pyridine 375 and 719-720 rim were considered to arise probably from bridging ligand to metal and terminal ligand to metal charge-transfer. The better luminescence observed for the mononuclear complex 4 as compared to dinuclear complex 5 was also found to be consistent with the earlier report [27] .
Antibacterial studies
The antibacterial activity of the ruthenium (II,I) complexes was evaluated against Pseudomonas aeruginosa and E. coli in DMSO solution (10"M) using the susceptibility testing method [28] as reported earlier [12] . Inhibitory effects by the free ligands (LH-L3H2) against Pseudomonas aerugmosa have been discussed earlier [12] by us. The data shown in Table IV better activity of complex 4 as compared to complex 1 against U87-MG was considered in terms of the presence of the bio-active benzimidazolyl group. The complex 5 did not show activity against any of both cells however it had a significant effect on the growth of only the glioblastoma cell line (clumping behaviour). A detailed mechanism ofthese activities is yet to be explored.
The anti-HIV activities (Table V) NA Not active inhibition < or 5% at 20 tg/mL.
*The sample was not active but had a significant unique impact on growth behaviour of U87-MG cells at 20
and 10 lag/mL. AZT Azido-thymidme
